MENU
IMCR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immunocore Holdings (IMCR) Ownership - Who owns Immunocore Holdings?

Immunocore Holdings PLC is a commercial-stage biotechnology company... Show more

Profile

Industry
N/A
Address
92 Park Drive
Phone
+44 1235438600
Employees
497
Web
https://www.immunocore.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.86B
P/E Ratio
N/A
Total Cash
892.35M
Projected Growth
N/A
Total Debt
435.86M
Revenue
379.59M
Risk (Beta)
1.28
Dividend Yield
N/A
Total Cash/Share
17.66
Total Debt/Equity
N/A
Revenue/Share
7.56 USD as % of share price

Fundamentals

IMCR
Capitalization
1.86B
P/E Ratio
N/A
Risk (Beta)
1.28
Dividend Yield
N/A
Total Cash
892M
Total Cash/Share
17.66
Total Debt
436M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.56%
Revenue
380M
ROE
N/A
Book Value
397M
P/B Ratio
4.69
Cash Flow
N/A
Earnings
-0.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
135K
Current Ratio
6.00
Current Revenue Per Employee
210330.62
Dividends Per Share - Security
N/A
EBITDA
-8.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
99.51
Revenue To Assets
-2.67
Shares Held By Institutions
2.44B
Shares Outstanding - Current
50.5M
Total Liabilities
706M
Total Volume MTD
N/A
Value
N/A
Gain YTD
21.356
View a ticker or compare two or three
IMCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMCR showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
92 Park Drive
Phone
+44 1235438600
Employees
497
Web
https://www.immunocore.com